Indian clinical research faces scrunity after child deaths
This article was originally published in Scrip
Executive Summary
India's clinical research sector expects to face increased scrutiny following the deaths of 49 children allegedly during clinical trials at the All-India Institute of Medical Sciences (AIIMS), New Delhi.